Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 6, 2006, Pages 1623-1628

  Dashe, Jodi S ^a   Twickler, Diane M ^a   Santos Ramos, Rigoberto ^a   McIntire, Donald D ^a   Ramus, Ronald M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Neural tube defects; Standard ultrasound

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ANALYTIC METHOD; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; NEWBORN PERIOD; PRENATAL PERIOD; PRIORITY JOURNAL; RISK; SCREENING; SENSITIVITY ANALYSIS; ULTRASOUND;

ADULT; ALPHA-FETOPROTEINS; EARLY DIAGNOSIS; FEMALE; GESTATIONAL AGE; HUMANS; LIKELIHOOD FUNCTIONS; NEURAL TUBE DEFECTS; PREGNANCY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 33751232012     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.03.097     Document Type: Article

References (21)

1. Wald N.J., and Cuckle H. Report of UK Collaborative Study on alpha-fetoprotein in relation to neural tube defects. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Lancet 8026 (1977) 1323-1332
2. Haddow J.E., Kloza E.M., Smith D.E., and Knight G.J. Data from an alpha-fetoprotein pilot screening program in Maine. Obstet Gynecol 62 (1983) 556-560
3. Burton B.K., Sowers S.G., and Nelson L.H. Maternal serum α-fetoprotein screening in North Carolina: Experience with more than twelve thousand pregnancies. Am J Obstet Gynecol 146 (1983) 439-444
4. Milunsky A., Jick S.S., Bruell C.L., MacLaughlin D.S., Tsung Y., Jick H., et al. Predictive values, relative risks, and overall benefits of high and low maternal serum α-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol 161 (1989) 291-297
5. Maternal serum screening. American College of Obstetricians and Gynecologists Educational Bulletin No. 228, September 1996.
6. Neural tube defects. American College of Obstetricians and Gynecologists. Practice Bulletin No. 44, July 2003.
7. Norem C.T., Schoen E.J., Walton D.L., Schoen E., Krieger R.C., O'Keefe J., et al. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening. Obstet Gynecol 106 (2005) 747-752
8. Nadel A.S., Green J.K., Holmes L.B., Frigoletto F.D., and Benacerraf B.R. Absence of need for amniocentesis in patients with elevated levels of maternal serum alpha-fetoprotein and normal ultrasonographic examinations. N Engl J Med 323 (1990) 557-561
9. Watson W.J., Chescheir N.C., Katz V.L., and Seeds J.W. The role of ultrasound in evaluation of patients with elevated maternal serum alpha-fetoprotein: a review. Obstet Gynecol 78 (1991) 123-128
10. Lennon C.A., and Gray D.L. Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high-risk population. Obstet Gynecol 94 (1999) 562-566
11. Martin J.A., Hamilton B.E., Sutton P.D., Ventura S.J., Menacker F., and Munson M.L. Births: final data for 2003. Natl Vital Stat Rep 54 (2005) 1-116
12. Casey B.M., Dashe J.S., Wells C.E., McIntire D.D., Byrd W., Leveno K.J., et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 105 (2005) 239-245
13. Butler E.L., Dashe J.S., and Ramus R.M. Association between maternal serum alpha-fetoprotein and adverse outcomes in pregnancies with placenta previa. Obstet Gynecol 97 (2001) 35-38
14. Ultrasonography in pregnancy. American College of Obstetricians and Gynecologists. Practice Bulletin No. 58, December 2004.
15. AIUM practice guideline for the performance of an antepartum obstetric ultrasound examination. J Ultrasound Med 22 (2003) 1116-1125
16. Dashe J.S., Casey B.M., Wells C.E., McIntire D.D., Byrd W., Leveno K.J., et al. Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol 106 (2005) 753-757
17. Nicolaides K.H., Campbell S., Gabbe S.G., and Guidetti R. Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet ii (1986) 71-74
18. Crane J.P., LeFevre M.L., Winborn R.C., Evans J.K., Ewigman B.G., Bain R.P., et al., the RADIUS study group. A randomized trial of prenatal ultrasonographic screening: Impact on the detection, management, and outcome of anomalous fetuses. Am J Obstet Gynecol 171 (1994) 393-399
19. VanDorsten J.P., Hulsey T.C., Newman R.B., and Menard M.K. Fetal anomaly detection by second-trimester ultrasonography in a tertiary center. Am J Obstet Gynecol 178 (1998) 742-749
20. Grandjean H., Larroque D., Levi S., and the Eurofetus study group. The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study. Am J Obstet Gynecol 181 (1999) 446-454
21. Scholtenhuis M.A.G.O., Cohen-Overbeek T.E., Offringa M., Barth P.G., Stoutenbeek P.H., Gooskens R.H., et al. Audit of prenatal and postnatal diagnosis of isolated open spina bifida in three university hospitals in The Netherlands. Ultrasound Obstet Gynecol 21 (2003) 48-52